The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients

Cited by (3,140)

Items 101–200 of 3,140

1. Association of Short-Chain Fatty Acids in the Gut Microbiome With Clinical Response to Treatment With Nivolumab or Pembrolizumab in Patients With Solid Cancer Tumors
   Nomura, Motoo, Nagatomo, Ryosuke, Doi, Keitaro, Shimizu, Juko, Baba, Kiichiro, Saito, Tomoki, Matsumoto, Shigemi, Inoue, Koichi, Muto, Manabu · 2020 · JAMA Network Open
2. Modulating the microbiome to improve therapeutic response in cancer
   McQuade, Jennifer L, Daniel, Carrie R, Helmink, Beth A, Wargo, Jennifer A · 2019 · The Lancet Oncology
3. The role of gut microbiota in cancer treatment: friend or foe?
   Cheng, Wing Yin, Wu, Chun-Ying, Yu, Jun · 2020 · Gut
4. Cancer and the Microbiome—Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy
   Matson, Vyara, Chervin, Carolina Soto, Gajewski, Thomas F. · 2021 · Gastroenterology
5. Environmental Factors, Gut Microbiota, and Colorectal Cancer Prevention
   Song, Mingyang, Chan, Andrew T. · 2019 · Clinical Gastroenterology and Hepatology
6. Multi-omics approaches in cancer research with applications in tumor subtyping, prognosis, and diagnosis
   Otília Menyhárt, Balázs Győrffy · 2021 · Computational and Structural Biotechnology Journal
7. Bacterial antagonism in host-associated microbial communities
   Leonor García-Bayona, Laurie E. Comstock · 2018 · Science
8. Immunometabolism: From basic mechanisms to translation
   Liza Makowski, Mehdi Chaib, Jeffrey C. Rathmell · 2020 · Immunological Reviews
9. Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer
   Aftab Alam, Eric Levanduski, Parker J. Denz, Helena Solleiro Villavicencio, Maulasri Bhatta, Lamees Alhorebi, Yali Zhang, Eduardo Cortes Gomez, Brian G. Morreale, Sharon Senchanthisai et al. · 2022 · Cancer Cell
10. Next generation probiotics in disease amelioration
    Chih‐Jung Chang, Tzu‐Lung Lin, Yu‐Ling Tsai, Tsung-Ru Wu, Wei-Fan Lai, Chia‐Chen Lu, Hsin‐Chih Lai · 2019 · Journal of Food and Drug Analysis
11. The Gut Microbiome Is Associated with Clinical Response to Anti–PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer
    Peng, Zhi, Cheng, Siyuan, Kou, Yan, Wang, Ziqi, Jin, Rong, Hu, Han, Zhang, Xiaotian, Gong, Ji-fang, Li, Jian, Lu, Ming et al. · 2020 · Cancer Immunology Research
12. Gut microbiome in HCC – Mechanisms, diagnosis and therapy
    Robert F. Schwabe, Tim F. Greten · 2020 · Journal of Hepatology
13. <i>Enterococcus</i> peptidoglycan remodeling promotes checkpoint inhibitor cancer immunotherapy
    Griffin, Matthew E., Espinosa, Juliel, Becker, Jessica L., Luo, Ji-Dung, Carroll, Thomas S., Jha, Jyoti K., Fanger, Gary R., Hang, Howard C. · 2021 · Science
14. Metabolic reprogramming for cancer cells and their microenvironment: Beyond the Warburg Effect
    Linchong Sun, Caixia Suo, Shiting Li, Huafeng Zhang, Ping Gao · 2018 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
15. The gut microbiota and colon cancer
    Wendy S. Garrett · 2019 · Science
16. Gut microbiome and its role in colorectal cancer
    Martina Reberšek · 2021 · BMC Cancer
17. The Oral Microbiome and Cancer
    Irfan, Muhammad, Delgado, Renata Zoraida Rizental, Frias-Lopez, Jorge · 2020 · Frontiers in Immunology
18. Microbiome and colorectal cancer: Roles in carcinogenesis and clinical potential
    Ester Saus, Susana Iraola‐Guzmán, Jesse R. Willis, Anna Brunet‐Vega, Toni Gabaldón · 2019 · Molecular Aspects of Medicine
19. Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
    Smith, Melody, Dai, Anqi, Ghilardi, Guido, Amelsberg, Kimberly V., Devlin, Sean M., Pajarillo, Raymone, Slingerland, John B., Beghi, Silvia, Herrera, Pamela S., Giardina, Paul et al. · 2022 · Nature Medicine
20. Advancing functional and translational microbiome research using meta-omics approaches
    Xu Zhang, Leyuan Li, James Butcher, Alain Stintzi, Daniel Figeys · 2019 · Microbiome
21. Bifidobacterium mechanisms of immune modulation and tolerance
    Samuel J. Gavzy, Allison Kensiski, Zachariah L Lee, Emmanuel F. Mongodin, Bing Ma, Jonathan S. Bromberg · 2023 · Gut Microbes
22. Bacteria in cancer initiation, promotion and progression
    Geniver El Tekle, Wendy S. Garrett · 2023 · Nature reviews. Cancer
23. Neutrophil phenotypes and functions in cancer: A consensus statement
    Daniela F. Quail, Borko Amulic, Monowar Aziz, Betsy Jo Barnes, Evgeniy B. Eruslanov, Zvi Gregorio Fridlender, Helen S. Goodridge, Zvi Granot, Andrés Hidalgo, Anna Huttenlocher et al. · 2022 · The Journal of Experimental Medicine
24. Bifidobacterium bifidum strains synergize with immune checkpoint inhibitors to reduce tumour burden in mice
    Lee, Se-Hoon, Cho, Sung-Yup, Yoon, Youngmin, Park, Changho, Sohn, Jinyoung, Jeong, Jin-Ju, Jeon, Bu-Nam, Jang, Mongjoo, An, Choa, Lee, Suro et al. · 2021 · Nature Microbiology
25. The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer
    Mirji, Gauri, Worth, Alison, Bhat, Sajad Ahmad, El Sayed, Mohamed, Kannan, Toshitha, Goldman, Aaron R., Tang, Hsin-Yao, Liu, Qin, Auslander, Noam, Dang, Chi V. et al. · 2022 · Science Immunology
26. Mining the microbiota for microbial and metabolite-based immunotherapies
    Skelly, Ashwin N., Sato, Yuko, Kearney, Sean, Honda, Kenya · 2019 · Nature Reviews Immunology
27. Gut microbiome, big data and machine learning to promote precision medicine for cancer
    Cammarota, Giovanni, Ianiro, Gianluca, Ahern, Anna, Carbone, Carmine, Temko, Andriy, Claesson, Marcus J., Gasbarrini, Antonio, Tortora, Giampaolo · 2020 · Nature Reviews Gastroenterology &amp; Hepatology
28. Antigen presentation in cancer — mechanisms and clinical implications for immunotherapy
    Kailin Yang, Ahmed Halima, Timothy An-thy Chan · 2023 · Nature Reviews Clinical Oncology
29. Lower Airway Dysbiosis Affects Lung Cancer Progression
    Tsay, Jun-Chieh J., Wu, Benjamin G., Sulaiman, Imran, Gershner, Katherine, Schluger, Rosemary, Li, Yonghua, Yie, Ting-An, Meyn, Peter, Olsen, Evan, Perez, Luisannay et al. · 2021 · Cancer Discovery
30. The Gut Microbiome Associates with Immune Checkpoint Inhibition Outcomes in Patients with Advanced Non–Small Cell Lung Cancer
    Hakozaki, Taiki, Richard, Corentin, Elkrief, Arielle, Hosomi, Yukio, Benlaïfaoui, Myriam, Mimpen, Iris, Terrisse, Safae, Derosa, Lisa, Zitvogel, Laurence, Routy, Bertrand et al. · 2020 · Cancer Immunology Research
31. Exploring the emerging role of the microbiome in cancer immunotherapy
    Jessica L. Fessler, Vyara Z. Matson, Thomas Frank Gajewski · 2019 · Journal for ImmunoTherapy of Cancer
32. Microbiota-specific T follicular helper cells drive tertiary lymphoid structures and anti-tumor immunity against colorectal cancer
    Overacre-Delgoffe, Abigail E., Bumgarner, Hannah J., Cillo, Anthony R., Burr, Ansen H.P., Tometich, Justin T., Bhattacharjee, Amrita, Bruno, Tullia C., Vignali, Dario A.A., Hand, Timothy W. · 2021 · Immunity
33. Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy
    Daixi Ren, Yuze Hua, Boyao Yu, Xin Ye, Ziheng He, Chunwei Li, Jie Wang, Yongzhen Mo, Xiaoxu Wei, Yunhua Chen et al. · 2020 · Molecular Cancer
34. Gut microbiota modulate dendritic cell antigen presentation and radiotherapy-induced antitumor immune response
    Uribe-Herranz, Mireia, Rafail, Stavros, Beghi, Silvia, Gil-de-Gómez, Luis, Verginadis, Ioannis, Bittinger, Kyle, Pustylnikov, Sergey, Pierini, Stefano, Perales-Linares, Renzo, Blair, Ian A. et al. · 2019 · Journal of Clinical Investigation
35. Unexpected guests in the tumor microenvironment: microbiome in cancer
    Abigail Wong-Rolle, Haohan Karen Wei, Chen Ning Zhao, Chengcheng Jin · 2020 · Protein & Cell
36. Metabolic interventions in the immune response to cancer
    David O’Sullivan, David E. Sanin, Edward J. Pearce, Erika L. Pearce · 2019 · Nature reviews. Immunology
37. Microbiota in pancreatic health and disease: the next frontier in microbiome research
    Ryan Michael Thomas, Christian Jobin · 2019 · Nature Reviews Gastroenterology & Hepatology
38. The oral–gut microbiome axis in health and disease
    Benoit Josef Kunath, Charlotte De Rudder, Cedric Christian Laczny, Elisabeth Letellier, Paul Wilmes · 2024 · Nature Reviews Microbiology
39. Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma
    Chen Chen, Zehua Wang, Yi Ding, Yanru Qin · 2023 · Frontiers in Immunology
40. Immuno-Oncology: Emerging Targets and Combination Therapies
    Henry T. Marshall, Mustafa B.A. Djamgoz · 2018 · Frontiers in Oncology
41. Microbiota transplantation: Concept, methodology and strategy for its modernization
    FMT-standardization Study Group, Zhang, Faming, Cui, Bota, He, Xingxiang, Nie, Yuqiang, Wu, Kaichun, Fan, Daiming · 2018 · Protein &amp; Cell
42. Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours
    Ashley M. Holder, Aikaterini Dedeilia, Kailan Sierra-Davidson, Sonia Cohen, David Liu, Aparna R. Parikh, Genevieve Marie Boland · 2024 · Nature reviews. Cancer
43. Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies
    Concetta Panebianco, Angelo Andriulli, Valerio Pazienza · 2018 · Microbiome
44. Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer
    Ruize Qu, Yi Zhang, Yanpeng Ma, Xin Zhou, Lulu Sun, Changtao Jiang, Zhipeng Zhang, Wei Fu · 2023 · Advanced Science
45. <i>Bifidobacterium</i> alters the gut microbiota and modulates the functional metabolism of T regulatory cells in the context of immune checkpoint blockade
    Sun, Shan, Luo, Lingjie, Liang, Wenhua, Yin, Qian, Guo, Jing, Rush, Anthony M., Lv, Zhibao, Liang, Qiming, Fischbach, Michael A., Sonnenburg, Justin L. et al. · 2020 · Proceedings of the National Academy of Sciences
46. Efficacy of chemotherapy and atezolizumab in patients with non-small-cell lung cancer receiving antibiotics and proton pump inhibitors: pooled post hoc analyses of the OAK and POPLAR trials
    Chalabi, M., Cardona, A., Nagarkar, D.R., Dhawahir Scala, A., Gandara, D.R., Rittmeyer, A., Albert, M.L., Powles, T., Kok, M., Herrera, F.G. · 2020 · Annals of Oncology
47. Immunotherapy, Inflammation and Colorectal Cancer
    Charles Robert Lichtenstern, Rachael Katie Ngu, Shabnam Shalapour, Michael Karin · 2020 · Cells
48. Immune-related toxicities of checkpoint inhibitors: mechanisms and mitigation strategies
    Ryan Joseph Sullivan, Jeffrey S. Weber · 2021 · Nature Reviews Drug Discovery
49. Relating the gut metagenome and metatranscriptome to immunotherapy responses in melanoma patients
    Peters, Brandilyn A., Wilson, Melissa, Moran, Una, Pavlick, Anna, Izsak, Allison, Wechter, Todd, Weber, Jeffrey S., Osman, Iman, Ahn, Jiyoung · 2019 · Genome Medicine
50. Generation of systemic antitumour immunity via the in situ modulation of the gut microbiome by an orally administered inulin gel
    Han, Kai, Nam, Jutaek, Xu, Jin, Sun, Xiaoqi, Huang, Xuehui, Animasahun, Olamide, Achreja, Abhinav, Jeon, Jin Heon, Pursley, Benjamin, Kamada, Nobuhiko et al. · 2021 · Nature Biomedical Engineering
51. TH17 cell heterogeneity and its role in tissue inflammation
    Schnell, Alexandra, Littman, Dan R., Kuchroo, Vijay K. · 2023 · Nature Immunology
52. Targeting the gut microbiota for cancer therapy
    Fernandes, Miriam R., Aggarwal, Poonam, Costa, Raquel G. F., Cole, Alicia M., Trinchieri, Giorgio · 2022 · Nature Reviews Cancer
53. Immunotherapy of Melanoma: Facts and Hopes
    Sarah Ann Weiss, Jedd D. Wolchok, Mario Sznol · 2019 · Clinical Cancer Research
54. Resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms, predictive factors, and future perspectives
    Jin‐Yu Sun, Dengke Zhang, Songquan Wu, Min Xu, Xiao Zhou, Xiaojie Lu, Jiansong Ji · 2020 · Biomarker Research
55. Tissue-resident Lachnospiraceae family bacteria protect against colorectal carcinogenesis by promoting tumor immune surveillance
    Xusheng Zhang, Yu Dou, Di Wu, Xintong Gao, Fei Shao, Min Zhao, Jiang Wang, Jiangwen Ma, Wenzhao Wang, Xiwen Qin et al. · 2023 · Cell Host & Microbe
56. Gut Microbiota Modulation of Efficacy and Toxicity of Cancer Chemotherapy and Immunotherapy
    Despoina Chrysostomou, Lauren A. Roberts, Julian Roberto Marchesi, James K. Kinross · 2022 · Gastroenterology
57. Lipid metabolism in T cell signaling and function
    Seon Ah Lim, WEI WEN SU, Nicole M. Chapman, Hongbo Chi · 2022 · Nature Chemical Biology
58. Design, construction, and in vivo augmentation of a complex gut microbiome
    Alice G. Cheng, Po-Yi Ho, Andrés Aranda-Díaz, Sunit Jain, Feiqiao Brian Yu, Xiandong Meng, Min Wang, Mikhail Iakiviak, Kazuki Nagashima, Aishan Zhao et al. · 2022 · Cell
59. Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes
    Nick Lung-Ngai Ting, Harry Cheuk-Hay Lau, Jun Qing Yu · 2022 · Gut
60. Commensal bacteria and fungi differentially regulate tumor responses to radiation therapy
    Stephen Lawrence Shiao, Kathleen M. Kershaw, Jose J. Limon, Sungyong You, Junhee Yoon, Emily Y. Ko, Jlenia Guarnerio, Alka A. Potdar, Dermot P.B. McGovern, Shikha Bose et al. · 2021 · Cancer Cell
61. Gut microbiome is associated with the clinical response to anti-PD-1 based immunotherapy in hepatobiliary cancers
    Jinzhu Mao, Dongxu Wang, Junyu Long, Yang Xu, Jianzhen Lin, Yiwei Song, Fucun Xie, Ziyu Xun, Yanyu Wang, Yunchao Wang et al. · 2021 · Journal for ImmunoTherapy of Cancer
62. The science and medicine of human immunology
    Bali Pulendran, Mark M. Davis · 2020 · Science
63. The Cancer Microbiome: Distinguishing Direct and Indirect Effects Requires a Systemic View
    João B. Xavier, Vincent Bensan Young, Joseph D. Skufca, Fiona Ginty, Traci L. Testerman, Alexander T. Pearson, Paul Macklin, Amir Mitchell, Ilya Shmulevich, Lei Xie et al. · 2020 · Trends in cancer
64. Revisit gut microbiota and its impact on human health and disease
    Ruixue Ding, Wei-Rui Goh, Rina Wu, Xiqing Yue, Xue Gang Luo, Wei Wei Thwe Khine, Junrui Wu, Yuan Kun Lee · 2019 · Journal of Food and Drug Analysis
65. The microbiota and microbiome in pancreatic cancer: more influential than expected
    Miao-Yan Wei, Si Shi, Chen Liang, Qing-Cai Meng, Jie Hua, Yi-Yin Zhang, Jiang Liu, Bo Zhang, Jin Xu, Xianjun Yu · 2019 · Molecular Cancer
66. Drug-microbiota interactions: an emerging priority for precision medicine
    Qing Chun Zhao, Yao Chen, Weihua Huang, Honghao Zhou, Wei Zhang · 2023 · Signal Transduction and Targeted Therapy
67. Enterocolitis due to immune checkpoint inhibitors: a systematic review
    Émilie Soularue, Patricia Lepage, Jean Frédéric Colombel, Clélia Coutzac, David M. Faleck, Lysiane Marthey, Michael Collins, Nathalie Chaput, Caroline Robert, Franck Carbonnel · 2018 · Gut
68. Potential Role of the Gut Microbiome In Colorectal Cancer Progression
    Jae-Ho Kim, Heung Kyu Lee · 2022 · Frontiers in Immunology
69. Biomarkers for immunotherapy response in head and neck cancer
    Niki Gavrielatou, S Doumas, Panagiota Economopoulou, Periklis G. Foukas, Amanda Psyrri · 2020 · Cancer Treatment Reviews
70. Host tissue determinants of tumour immunity
    Hélène Salmon, Romain Remark, Sacha Gnjatic, Miriam Mérad · 2019 · Nature reviews. Cancer
71. Gut Microbiome Directs Hepatocytes to Recruit MDSCs and Promote Cholangiocarcinoma
    Qianfei Zhang, Chi Ma, Yi Duan, Bernd Heinrich, Umberto Rosato, Laurence P. Diggs, Lichun Ma, Soumen Roy, Qiong Fu, Zachary J. Brown et al. · 2020 · Cancer Discovery
72. Immunotherapy in Melanoma: Recent Advances and Future Directions
    Andrew Knight, Lilit Karapetyan, John M. Kirkwood · 2023 · Cancers
73. Association of Probiotic <i>Clostridium butyricum</i> Therapy with Survival and Response to Immune Checkpoint Blockade in Patients with Lung Cancer
    Tomita, Yusuke, Ikeda, Tokunori, Sakata, Shinya, Saruwatari, Koichi, Sato, Ryo, Iyama, Shinji, Jodai, Takayuki, Akaike, Kimitaka, Ishizuka, Shiho, Saeki, Sho et al. · 2020 · Cancer Immunology Research
74. Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiome
    Simpson, Rebecca C., Shanahan, Erin R., Batten, Marcel, Reijers, Irene L. M., Read, Mark, Silva, Ines P., Versluis, Judith M., Ribeiro, Rosilene, Angelatos, Alexandra S., Tan, Jian et al. · 2022 · Nature Medicine
75. The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation
    Md. Mominur Rahman, Fahadul Islam, Md. Harun-Or-Rashid, Abdullah Al Mamun, Md. Saidur Rahaman, Md. Mohaimenul Islam, Atkia Farzana Khan Meem, Popy Rani Sutradhar, Saikat Mitra, Anjuman Ara Mimi et al. · 2022 · Frontiers in Cellular and Infection Microbiology
76. Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome
    Ziying Zhang, Haosheng Tang, Peng Chen, Hui Xie, Yongguang Tao · 2019 · Signal Transduction and Targeted Therapy
77. Gut microbiome and cancer immunotherapy
    Weina Li, Yu Deng, Qian Chu, Peng Zhang · 2019 · Cancer Letters
78. Microbiome: Focus on Causation and Mechanism
    Michael Andrew Fischbach · 2018 · Cell
79. A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy
    Stein-Thoeringer, Christoph K., Saini, Neeraj Y., Zamir, Eli, Blumenberg, Viktoria, Schubert, Maria-Luisa, Mor, Uria, Fante, Matthias A., Schmidt, Sabine, Hayase, Eiko, Hayase, Tomo et al. · 2023 · Nature Medicine
80. The negative impact of antibiotics on outcomes in cancer patients treated with immunotherapy: a new independent prognostic factor?
    Elkrief, A., Derosa, L., Kroemer, G., Zitvogel, L., Routy, B. · 2019 · Annals of Oncology
81. A Natural Polyphenol Exerts Antitumor Activity and Circumvents Anti–PD-1 Resistance through Effects on the Gut Microbiota
    Messaoudene, Meriem, Pidgeon, Reilly, Richard, Corentin, Ponce, Mayra, Diop, Khoudia, Benlaifaoui, Myriam, Nolin-Lapalme, Alexis, Cauchois, Florent, Malo, Julie, Belkaid, Wiam et al. · 2022 · Cancer Discovery
82. Mechanisms of immune activation and regulation: lessons from melanoma
    Shelly Kalaora, Adi Nagler, Jennifer Ann Wargo, Yardena Samuels · 2022 · Nature reviews. Cancer
83. Chemically and Biologically Engineered Bacteria‐Based Delivery Systems for Emerging Diagnosis and Advanced Therapy
    Zhaoting Li, Yixin Wang, Jun Liu, Piper A. Rawding, Jiyoon Bu, Seungpyo Hong, Quanyin Hu · 2021 · Advanced Materials
84. Crosstalk between Gut Microbiota and Host Immunity: Impact on Inflammation and Immunotherapy
    Connor Campbell, Mrunmayee R. Kandalgaonkar, Rachel M. Golonka, Beng San Yeoh, Matam Vijay–Kumar, Piu Saha · 2023 · Biomedicines
85. Emerging immunotherapy for HCC: A guide for hepatologists
    Friedrich Foerster, Simon Johannes Gairing, Sumera Irie Ilyas, Peter R. Galle · 2022 · Hepatology
86. Disordered gut microbiota and alterations in metabolic patterns are associated with atrial fibrillation
    Kun Zuo, Jing Li, Kuibao Li, Chaowei Hu, Yuanfeng Gao, Mulei Chen, Roumu Hu, Ye Liu, Hongjie Chi, Hongjiang Wang et al. · 2019 · GigaScience
87. Immune checkpoints in the tumor microenvironment
    Salman M. Toor, Varun Sasidharan Nair, Julie V. Decock, Eyad Elkord · 2019 · Seminars in Cancer Biology
88. The cutting-edge progress of immune-checkpoint blockade in lung cancer
    Fei Zhou, Meng Qiao, Caicun Zhou · 2020 · Cellular and Molecular Immunology
89. Pas de Deux: Control of Anti-tumor Immunity by Cancer-Associated Inflammation
    Shabnam Shalapour, Michael Karin · 2019 · Immunity
90. Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective From the International Association for the Study of Lung Cancer Pathology Committee
    Mari A. Mino-Kenudson, Kurt Alex Schalper, Wendy A. Cooper, Sanja Đačić, Fred R. Hirsch, Deepali Jain, Fernando López‐Ríos, Ming‐Sound Tsao, Yasushi Yatabe, Mary Beth Beasley et al. · 2022 · Journal of Thoracic Oncology
91. Imbalanced gut microbiota fuels hepatocellular carcinoma development by shaping the hepatic inflammatory microenvironment
    Schneider, Kai Markus, Mohs, Antje, Gui, Wenfang, Galvez, Eric J. C., Candels, Lena Susanna, Hoenicke, Lisa, Muthukumarasamy, Uthayakumar, Holland, Christian H., Elfers, Carsten, Kilic, Konrad et al. · 2022 · Nature Communications
92. Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer
    Shilong Zhang, Yuqin Mao, Zheng-Yan Zhang, Zhanming Li, Chao‐Yue Kong, Huiling Chen, Pei‐Ran Cai, Bing Han, Tao Ye, Li‐Shun Wang · 2021 · Theranostics
93. Gut dysbiosis promotes prostate cancer progression and docetaxel resistance via activating NF-κB-IL6-STAT3 axis
    Weibo Zhong, Kaihui Wu, Zining Long, Xumin Zhou, Chuanfan Zhong, Shuo Wang, Houhua Lai, Yufei Guo, Daojun Lv, Jianming Lü et al. · 2022 · Microbiome
94. Microbial metabolite butyrate promotes anti-PD-1 antitumor efficacy by modulating T cell receptor signaling of cytotoxic CD8 T cell
    Zhu, Xinhai, Li, Ke, Liu, Guichao, Wu, Ruan, Zhang, Yan, Wang, Siying, Xu, Meng, Lu, Ligong, Li, Peng · 2023 · Gut Microbes
95. A pan-cancer analysis of the microbiome in metastatic cancer
    Thomas Battaglia, Iris L. Mimpen, Joleen J.H. Traets, Arne van Hoeck, Laurien Joanna Zeverijn, Birgit S. Geurts, Gijs F. de Wit, Michaël Noë, Ingrid Hofland, Joris L. Vos et al. · 2024 · Cell
96. The promise of the gut microbiome as part of individualized treatment strategies
    Schupack, Daniel A., Mars, Ruben A. T., Voelker, Dayne H., Abeykoon, Jithma P., Kashyap, Purna C. · 2022 · Nature Reviews Gastroenterology &amp; Hepatology
97. Antibiotics are associated with decreased progression-free survival of advanced melanoma patients treated with immune checkpoint inhibitors
    Elkrief, Arielle, El Raichani, Layal, Richard, Corentin, Messaoudene, Meriem, Belkaid, Wiam, Malo, Julie, Belanger, Karl, Miller, Wilson, Jamal, Rahima, Letarte, Nathalie et al. · 2019 · OncoImmunology
98. Biomarkers for Clinical Benefit of Immune Checkpoint Inhibitor Treatment—A Review From the Melanoma Perspective and Beyond
    Kristina Buder‐Bakhaya, Jessica C. Hassel · 2018 · Frontiers in Immunology
99. Transgenic Mouse Models in Cancer Research
    Urša Lampreht Tratar, Simon Horvat, Maja Čemažar · 2018 · Frontiers in Oncology
100. Emerging role of bacterial extracellular vesicles in cancer
     Antonios Chronopoulos, Raghu Kalluri · 2020 · Oncogene